Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP438781.RApX-EFeu5v4jBg9ulO_Y4vvAV3sKYegTB6y_BtfsGwk4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP438781.RApX-EFeu5v4jBg9ulO_Y4vvAV3sKYegTB6y_BtfsGwk4130_assertion type Assertion NP438781.RApX-EFeu5v4jBg9ulO_Y4vvAV3sKYegTB6y_BtfsGwk4130_head.
- NP438781.RApX-EFeu5v4jBg9ulO_Y4vvAV3sKYegTB6y_BtfsGwk4130_assertion description "[If CD19 or CD22 positive B-lymphocytes are part of the myeloma clone, there should be evidence of myeloma-specific genetic markers in this population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP438781.RApX-EFeu5v4jBg9ulO_Y4vvAV3sKYegTB6y_BtfsGwk4130_provenance.
- NP438781.RApX-EFeu5v4jBg9ulO_Y4vvAV3sKYegTB6y_BtfsGwk4130_assertion evidence source_evidence_literature NP438781.RApX-EFeu5v4jBg9ulO_Y4vvAV3sKYegTB6y_BtfsGwk4130_provenance.
- NP438781.RApX-EFeu5v4jBg9ulO_Y4vvAV3sKYegTB6y_BtfsGwk4130_assertion SIO_000772 15068900 NP438781.RApX-EFeu5v4jBg9ulO_Y4vvAV3sKYegTB6y_BtfsGwk4130_provenance.
- NP438781.RApX-EFeu5v4jBg9ulO_Y4vvAV3sKYegTB6y_BtfsGwk4130_assertion wasDerivedFrom befree-2016 NP438781.RApX-EFeu5v4jBg9ulO_Y4vvAV3sKYegTB6y_BtfsGwk4130_provenance.
- NP438781.RApX-EFeu5v4jBg9ulO_Y4vvAV3sKYegTB6y_BtfsGwk4130_assertion wasGeneratedBy ECO_0000203 NP438781.RApX-EFeu5v4jBg9ulO_Y4vvAV3sKYegTB6y_BtfsGwk4130_provenance.